Bluestem Biosciences, Inc.
PrivateLast Round
Grant
Oct 1, 2025
Total Funding Raised
$18.34M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Bluestem Biosciences, Inc. operates in Energy & Sustainability and is based in Omaha, Nebraska. Its latest recorded funding round was a Grant round in October 2025.
Bluestem Biosciences, Inc. is a biotechnology company that develops a digital biology platform designed for the sustainable production of chemicals through proprietary anaerobic fermentation.
Sector
Energy & Sustainability
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bluestem Biosciences, Inc. Comparables
Compare Bluestem Biosciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Låkril Technologies | 90% | |
| ZymoChem | 77% | |
| Industrial Microbes | 69% |
For institutional investors. Book with your work email.
Bluestem Biosciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 1, 2025 | ||||
| Grant | Jan 16, 2025 | ||||
| Grant | Sep 13, 2024 | ||||
| Pre Seed | Aug 9, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bluestem Biosciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zero Infinity Partners | Pre Seed |
| U.S. Department of War | Grant |
| Invest Nebraska | Pre Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 232% MoM, reaching 1.9K.
- May 1, 2025
Monthly visitors increased 112% MoM, reaching 1.8K.
For institutional investors. Book with your work email.
Bluestem Biosciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bluestem Biosciences, Inc.'s valuation, stock price, and market status.
Is Bluestem Biosciences, Inc. a public or private company?
Bluestem Biosciences, Inc. is a private company.
What is the current stock price of Bluestem Biosciences, Inc.?
Bluestem Biosciences, Inc. is a private company, so its shares have no public market price. Caplight tracks Bluestem Biosciences, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bluestem Biosciences, Inc. worth (valuation)?
Valuation information for Bluestem Biosciences, Inc. is not publicly available.
Can I buy Bluestem Biosciences, Inc. stock?
Bluestem Biosciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bluestem Biosciences, Inc.'s last funding round?
Bluestem Biosciences, Inc.'s most recent funding round was Grant on October 1, 2025.
Who are the main investors in Bluestem Biosciences, Inc.?
Key investors in Bluestem Biosciences, Inc. include Zero Infinity Partners.
Will Bluestem Biosciences, Inc. IPO soon?
No public IPO plans have been announced for Bluestem Biosciences, Inc..
How can I track Bluestem Biosciences, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Bluestem Biosciences, Inc.'s shares on secondary markets.